Visual outcomes of photorefractive keratectomy in non-children with anisometropic amblyopia: One-year Follow-up Outcomes

医学 眼科 光折变性角膜切除术 立体视敏度 屈光参差 验光服务 折射误差 视力
作者
Mohammad Etezad-Razavi,Bahar Tafaghodi-Yousefi,Alireza Eslampour,Mohammad Yaser Kiarudi,Marzieh Najjaran,Hamed Momeni‐Moghaddam,Jorge L. Alió
出处
期刊:European Journal of Ophthalmology [SAGE Publishing]
卷期号:32 (5): 2615-2621 被引量:1
标识
DOI:10.1177/11206721211073033
摘要

Objective To evaluate the safety, efficiency, short term stability, and sensory results of photorefractive keratectomy (PRK) in anisometropic in non-compliant children with correction. Methods Twelve eyes of 12 children with an age range: 6–17 years and anisometropic amblyopia who underwent PRK under general anesthesia to correct the dioptric difference between the eyes were included in this study. A complete ophthalmic assessment including refractive status, uncorrected and corrected distance visual acuity (UDVA & CDVA), and binocular vision status using the Worth 4-dot test and stereopsis were performed before and 1, 3, 6, and 12 months after PRK. Results The mean preoperative CDVA was 0.34 ± 0.24 LogMAR which showed a statistically significant improvement at 12 months (0.20 ± 0.19, p = 0.024) after surgery compared to the preoperative assessment. (p = 0.003) The mean preoperative UDVA was 0.63 ± 0.24 LogMAR that increased to 0.44 ± 0.24, 0.32 ± 0.16, 0.25 ± 0.19, and 0.25 ± 0.19 LogMAR at 1, 3, 6, and 12 months after PRK, respectively. One to three lines improvement in UDVA and CDVA was seen in 10 (83.4%) and 8 eyes (66.7%); while one line UDVA and CDVA loss was seen in one (8.3%) and one (8.3%) eye and unchanged UDVA and CDVA was seen in 1 (8.3%) and 3 eyes (25%), respectively. The mean preoperative stereoacuity was 341.9 ± 245.7 s of arc, which significantly improved to 166.6 ± 87.5 s of arc 12 months after PRK. (p = 0.012) Conclusion PRK was an effective surgical alternative to improve visual acuity and stereopsis in anisometropic children who did not cooperate with conventional methods of amblyopia therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
2秒前
隋阳完成签到 ,获得积分10
2秒前
王好让发布了新的文献求助10
3秒前
汉堡包应助CC采纳,获得10
3秒前
Lucas应助闪闪紫采纳,获得10
3秒前
feifei完成签到,获得积分10
3秒前
花痴的慕蕊完成签到,获得积分10
5秒前
小二郎应助苹果采纳,获得10
5秒前
FashionBoy应助WYJ采纳,获得10
5秒前
5秒前
小白发布了新的文献求助10
5秒前
7秒前
ddddyooo发布了新的文献求助10
11秒前
小蘑菇应助zhang005on采纳,获得10
11秒前
救救我发布了新的文献求助10
11秒前
MOFS发布了新的文献求助10
13秒前
研友_RLNDkZ发布了新的文献求助10
13秒前
纯真以松发布了新的文献求助20
13秒前
科研通AI2S应助搬砖人采纳,获得10
14秒前
14秒前
bin_zhang完成签到,获得积分10
14秒前
15秒前
Owen应助科研通管家采纳,获得10
16秒前
完美世界应助科研通管家采纳,获得10
16秒前
16秒前
16秒前
16秒前
爆米花应助科研通管家采纳,获得10
16秒前
16秒前
田様应助科研通管家采纳,获得10
16秒前
16秒前
16秒前
16秒前
李爱国应助科研通管家采纳,获得10
16秒前
16秒前
Twonej应助笑哈哈采纳,获得30
16秒前
在水一方应助从容寄凡采纳,获得10
17秒前
大模型应助iii采纳,获得10
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Digital Twins of Advanced Materials Processing 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6039756
求助须知:如何正确求助?哪些是违规求助? 7771167
关于积分的说明 16227940
捐赠科研通 5185772
什么是DOI,文献DOI怎么找? 2775087
邀请新用户注册赠送积分活动 1757977
关于科研通互助平台的介绍 1641955